TOKYOMEDIJAPAN MEDICAL REFERENCE
⌕ Pesquisar baseFonte oficial · PMDA / MHLW
JAPAN MEDICINE REFERENCE

Medicamentos japoneses

Search Japanese product names, generics, brands, marketing authorization holders, strengths and PMDA primary sources. Prescription medicines are reference-only and are not sold online.

15 records
Filter by therapeutic area
ノルバスク錠2.5mg/5mg/10mg・ノルバスクOD錠2.5mg/5mg/10mg · 5 mgJapanese product photo · 5 mg · PETMEDIC PRO
CardiovascularRx

Norvasc

Amlodipine · ノルバスク錠2.5mg/5mg/10mg・ノルバスクOD錠2.5mg/5mg/10mg

Main use

Mainly used for high blood pressure and angina.

tablet / OD tablet2.5 mg / 5 mg / 10 mgヴィアトリス製薬合同会社
PMDAView full reference →
オプジーボ点滴静注20mg/100mg/120mg/240mg · 100 mg / 10 mLJapanese product photo · 100 mg / 10 mL · BMS Oncology Japan
OncologiaRx

Opdivo

Nivolumab · オプジーボ点滴静注20mg/100mg/120mg/240mg

Main use

Used for selected cancers, including melanoma, lung and kidney cancer, under disease-specific conditions.

IV infusion20 mg / 100 mg / 120 mg / 240 mg小野薬品工業株式会社
PMDAView full reference →
キイトルーダ点滴静注100mg · 100 mg / 4 mLJapanese product photo · 100 mg / 4 mL · MSD Connect
OncologiaRx

Keytruda

Pembrolizumab · キイトルーダ点滴静注100mg

Main use

Used for selected cancers such as melanoma and lung cancer, depending on cancer type, stage or biomarkers.

IV infusion100 mgMSD株式会社
PMDAView full reference →
タグリッソ錠40mg/80mg · 40 mg / 80 mgJapanese product photo · 40 mg / 80 mg · CareNet
OncologiaRx

Tagrisso

Osimertinib · タグリッソ錠40mg/80mg

Main use

Used for certain EGFR mutation-positive non-small-cell lung cancers.

tablet40 mg / 80 mgアストラゼネカ株式会社
PMDAView full reference →
エンハーツ点滴静注用100mg · 100 mgJapanese product photo · 100 mg · 日刊工業新聞
OncologiaRx

Enhertu

Trastuzumab deruxtecan · エンハーツ点滴静注用100mg

Main use

Used for selected breast, stomach, lung and other solid cancers meeting specific HER2 criteria.

IV infusion100 mg第一三共株式会社
PMDAView full reference →
レケンビ点滴静注200mg/500mg · 500 mg / 5 mLJapanese product photo · 500 mg / 5 mL · エーザイ Medical
NeurologiaRx

Leqembi

Lecanemab · レケンビ点滴静注200mg/500mg

Main use

Used to slow progression of mild cognitive impairment or mild dementia due to Alzheimer’s disease.

IV infusion200 mg / 500 mgエーザイ株式会社
PMDAView full reference →
エンレスト錠50mg/100mg/200mg・粒状錠小児用12.5mg/31.25mg · 50 mgJapanese product photo · 50 mg · ノバルティス ファーマ
CardiovascularRx

Entresto

Sacubitril / valsartan · エンレスト錠50mg/100mg/200mg・粒状錠小児用12.5mg/31.25mg

Main use

Mainly used for chronic heart failure; some strengths are also approved for hypertension.

tablet / pediatric granule tablet50 mg / 100 mg / 200 mg; pediatric 12.5 mg / 31.25 mgノバルティスファーマ株式会社
PMDAView full reference →
ジャディアンス錠10mg/25mg · 10 mgJapanese product photo · 10 mg · ベーリンガーインゲルハイム
MetabólicoRx

Jardiance

Empagliflozin · ジャディアンス錠10mg/25mg

Main use

Used for type 2 diabetes; the 10 mg product is also used for certain chronic heart failure and kidney disease.

tablet10 mg / 25 mg日本ベーリンガーインゲルハイム株式会社
PMDAView full reference →
リベルサス錠3mg/7mg/14mg · 3 mg / 7 mgJapanese product photo · 3 mg / 7 mg · Windshear / CC BY-SA 4.0
MetabólicoRx

Rybelsus

Semaglutide · リベルサス錠3mg/7mg/14mg

Main use

This Rybelsus oral-tablet record is for type 2 diabetes.

oral tablet3 mg / 7 mg / 14 mgノボ ノルディスク ファーマ株式会社
PMDAView full reference →
リクシアナ錠15mg/30mg/60mg · 30 mgJapanese product photo · 30 mg · 関西薬品
CardiovascularRx

Lixiana

Edoxaban · リクシアナ錠15mg/30mg/60mg

Main use

Used to reduce stroke risk in certain atrial fibrillation and to treat or prevent venous blood clots.

tablet15 mg / 30 mg / 60 mg第一三共株式会社
PMDAView full reference →
サムスカOD錠7.5mg/15mg/30mg・サムスカ顆粒1% · OD 7.5 mg / 15 mg / 30 mgJapanese product photo · OD 7.5 mg / 15 mg / 30 mg · 大塚製薬
CardiovascularRx

Samsca

Tolvaptan · サムスカOD錠7.5mg/15mg/30mg・サムスカ顆粒1%

Main use

Depending on strength, used for fluid retention, SIADH-related low sodium, or selected polycystic kidney disease.

OD tablet / granules7.5 mg / 15 mg / 30 mg; granules 1%大塚製薬株式会社
PMDAView full reference →
ピレスパ錠200mg · 200 mgJapanese product photo · 200 mg · 塩野義製薬
RespiratórioRx

Pirespa

Pirfenidone · ピレスパ錠200mg

Main use

Used for idiopathic pulmonary fibrosis.

tablet200 mg塩野義製薬株式会社
PMDAView full reference →
デュピクセント皮下注300mg/200mg ペン・シリンジ · 300 mg / 2 mLJapanese product photo · 300 mg / 2 mL · Lyall0 / CC BY-SA 4.0
ImunologiaRx

Dupixent

Dupilumab · デュピクセント皮下注300mg/200mg ペン・シリンジ

Main use

Used for selected inflammatory conditions such as atopic dermatitis and severe asthma, depending on formulation.

SC pen / syringe200 mg / 300 mgサノフィ株式会社
PMDAView full reference →
リンヴォック錠7.5mg/15mg/30mg/45mg・内用液0.1% · 7.5 mg / 15 mgJapanese product photo · 7.5 mg / 15 mg · アッヴィ / 共同通信PRワイヤー
ImunologiaRx

Rinvoq

Upadacitinib · リンヴォック錠7.5mg/15mg/30mg/45mg・内用液0.1%

Main use

Used for selected rheumatoid arthritis, atopic dermatitis and inflammatory bowel disease, depending on formulation.

tablet / oral solution7.5 mg / 15 mg / 30 mg / 45 mg; oral solution 0.1%アッヴィ合同会社
PMDAView full reference →
スキリージ皮下注55mg/75mg/150mg シリンジ・150mgペン · 150 mg / 1 mL penJapanese product photo · 150 mg / 1 mL pen · スキリージ.jp / アッヴィ
ImunologiaRx

Skyrizi

Risankizumab · スキリージ皮下注55mg/75mg/150mg シリンジ・150mgペン

Main use

The subcutaneous products on this page are mainly used for plaque psoriasis and psoriatic arthritis.

SC syringe / pen55 mg / 75 mg / 150 mgアッヴィ合同会社
PMDAView full reference →
PMDAPrimary sources first

Approval status, labels, safety information and current revisions should be confirmed in official Japanese sources such as PMDA. TOKYO MEDI provides a reference index and verification context, not a replacement for official documents.

PMDA ↗